Successful isavuconazole salvage therapy for cerebral mucormycosis in a child with relapsed leukemia: A light in the dark tunnel-Reference-Cited by-同舟云学术

Successful isavuconazole salvage therapy for cerebral mucormycosis in a child with relapsed leukemia: A light in the dark tunnel

Published:2022-06-03 Issue:1 Volume:70 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Alali Muayad¹^ORCID,Balsara Karl²,Khaitan Alka¹,Streicher Drew A.³,Barros Kathryn L.¹,Budnick Hailey C.²,Schulte Rachael R.⁴

Affiliation:

1. Department of Pediatrics, Ryan White Center for Pediatric, Infectious Diseases and Global Health Indiana University School of Medicine Indianapolis Indiana USA

2. Department of Neurosurgery, Goodman Campbell Brain and Spine, Riley Hospital for Children, Section of Pediatric Neurosurgery Indiana University School of Medicine Indianapolis Indiana USA

3. Department of Radiology Indiana University School of Medicine Indianapolis Indiana USA

4. Department of Pediatrics, Section of Hematology/Oncology Indiana University School of Medicine Indianapolis Indiana USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29807

Reference27 articles.

1. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

2. Fungal infections of the central nervous system and paranasal sinuses in onco‐haematologic patients. Epidemiological study reporting the diagnostic‐therapeutic approach and outcome in 89 cases

3. Zygomycosis (Mucormycosis) and HIV Infection: Report of Three Cases and Review

4. Isolated Central Nervous System Mucormycosis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute myocardial infarction caused by coronary mucormycotic embolism;IDCases;2023

2. Clinical research advances of isavuconazole in the treatment of invasive fungal diseases;Frontiers in Cellular and Infection Microbiology;2022-12-01